Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1993 1
1995 2
1996 9
1997 6
1998 5
1999 1
2000 1
2001 4
2002 5
2003 6
2004 16
2005 17
2006 14
2007 19
2008 23
2009 14
2010 11
2011 6
2012 12
2013 14
2014 12
2015 17
2016 16
2017 13
2018 15
2019 9
2020 19
2021 16
2022 20
2023 22
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib versus methotrexate in rheumatoid arthritis.
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators. Lee EB, et al. N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476. N Engl J Med. 2014. PMID: 24941177 Free article. Clinical Trial.
Editorial: Artificial Intelligence for eHealth.
Gupta D, Rodrigues JJPC, Peng SL, Nguyen N. Gupta D, et al. Among authors: peng sl. Front Public Health. 2022 Mar 4;10:852840. doi: 10.3389/fpubh.2022.852840. eCollection 2022. Front Public Health. 2022. PMID: 35309212 Free PMC article. No abstract available.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: peng sl. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases.
Evans LS, Lewis KE, DeMonte D, Bhandari JG, Garrett LB, Kuijper JL, Ardourel D, Wolfson MF, Debrot S, Mudri S, Kleist K, Griffin LL, Hebb L, Sanderson RJ, Wang N, Seaberg M, Chunyk AG, Yang J, Hong Y, Maria Z, Messenheimer DJ, Holland PM, Peng SL, Rixon MW, Dillon SR. Evans LS, et al. Among authors: peng sl. Arthritis Rheumatol. 2023 Jul;75(7):1187-1202. doi: 10.1002/art.42462. Epub 2023 Apr 19. Arthritis Rheumatol. 2023. PMID: 36705554
Progress on plant orphan genes.
Jiang ML, Lang H, Li XN, Zu Y, Zhao J, Peng SL, Liu Z, Zhan ZX, Piao ZY. Jiang ML, et al. Among authors: peng sl. Yi Chuan. 2022 Aug 20;44(8):682-694. doi: 10.16288/j.yczz.22-154. Yi Chuan. 2022. PMID: 36384667 Review.
Surgical adhesives in ophthalmology: history and current trends.
Guhan S, Peng SL, Janbatian H, Saadeh S, Greenstein S, Al Bahrani F, Fadlallah A, Yeh TC, Melki SA. Guhan S, et al. Among authors: peng sl. Br J Ophthalmol. 2018 Oct;102(10):1328-1335. doi: 10.1136/bjophthalmol-2017-311643. Epub 2018 Mar 26. Br J Ophthalmol. 2018. PMID: 29581352 Review.
Forkhead transcription factors in immunology.
Jonsson H, Peng SL. Jonsson H, et al. Among authors: peng sl. Cell Mol Life Sci. 2005 Feb;62(4):397-409. doi: 10.1007/s00018-004-4365-8. Cell Mol Life Sci. 2005. PMID: 15719167 Review.
320 results